Poli A, Catapano AL, Corsini A, Manzato E, Werba JP, Catena G, Cetin I, Cicero AFG, Cignarella A, Colivicchi F, Consoli A, Landi F, Lucarelli M, Manfellotto D, Marrocco W, Parretti D, Perrone Filardi P, Pirillo A, Sesti G, Volpe M, Marangoni F, LDL-cholesterol control in the primary prevention of cardiovascular diseases: An expert opinion for clinicians and health professionals, «NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES», 2023, 33, pp. 245 - 257 [articolo]Open Access
Fogacci F, Giovannini M, Imbalzano E, Grandi E, Rizzoli E, D'Addato S, Cicero AFG, Metabolic and vascular effect of a new standardized bergamot phytocomplex: a three-arm, placebocontrolled, double-blind clinical trial, «ARCHIVES OF MEDICAL SCIENCE», 2023, 19, pp. 1228 - 1235 [articolo]Open Access
Risoli S, Nali C, Sarrocco S, Cicero AFG, Colletti A, Bosco F, Venturella G, Gadaleta A, Gargano ML, Marcotuli I., Mushroom-Based Supplements in Italy: Let’s Open Pandora’s Box, «NUTRIENTS», 2023, 15, Article number: 776, pp. 1 - 14 [articolo]Open Access
Orlando L, Bagnato G, Ioppolo C, Franzè MS, Perticone M, Versace AG, Sciacqua A, Russo V, Cicero AFG, De Gaetano A, Dattilo G, Fogacci F, Tringali MC, Di Micco P, Squadrito G, Imbalzano E., Natural Course of COVID-19 and Independent Predictors of Mortality., «BIOMEDICINES», 2023, 11, Article number: 939, pp. 1 - 9 [articolo]Open Access
Rizzo M, Colletti A, Penson PE, Katsiki N, Mikhailidis DP, Toth PP, Gouni-Berthold I, Mancini J, Marais D, Moriarty P, Ruscica M, Sahebkar A, Vinereanu D, Cicero AFG, Banach M; International Lipid Expert Panel (ILEP), Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP), «PHARMACOLOGICAL RESEARCH», 2023, 189, Article number: 106679, pp. 1 - 21 [articolo]Open Access
Borghi, Claudio; Cicero, Arrigo Fg; Agnoletti, Davide; Fiorini, Giulia, Pathophysiology of cough with angiotensin-converting enzyme inhibitors: How to explain within-class differences?, «EUROPEAN JOURNAL OF INTERNAL MEDICINE», 2023, 110, pp. 10 - 15 [articolo]Open Access
Avagimyan A, Sheibani M, Pogosova N, Mkrtchyan L, Yeranosyan H, Aznauryan A, Sahaakyan K, Fogacci F, Cicero A, Shafie D, Sarrafzadegan N, Possibilities of dapagliflozin-induced cardioprotection on doxorubicin + cyclophosphamide mode of chemotherapy-induced cardiomyopathy, «INTERNATIONAL JOURNAL OF CARDIOLOGY», 2023, 391, Article number: 131331, pp. 1 - 9 [articolo]
Fogacci F, Rizzo M, Cicero AFG, PUFA treatment in patients with gestational diabetes mellitus: Lights and shadows, «JOURNAL OF DIABETES AND ITS COMPLICATIONS», 2023, 37, pp. 1 - 2 [articolo]Open Access
Cicero AFG, Fogacci F, Di Micoli V, Angeloni C, Giovannini M, Borghi C, Purine Metabolism Dysfunctions: Experimental Methods of Detection and Diagnostic Potential, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2023, 24, Article number: 7027, pp. 1 - 14 [articolo]Open Access
Cicero AFG, Fogacci F, Stoian AP, Toth PP., Red Yeast Rice for the Improvement of Lipid Profiles in Mild-to-Moderate Hypercholesterolemia: A Narrative Review, «NUTRIENTS», 2023, 15, Article number: 2288, pp. 1 - 28 [articolo]Open Access
Cicero AFG, Fogacci F, D'Addato S, Grandi E, Rizzoli E, Borghi C, On Behalf Of The Brisighella Heart Study., Self-Reported Coffee Consumption and Central and Peripheral Blood Pressure in the Cohort of the Brisighella Heart Study., «NUTRIENTS», 2023, 15, Article number: 312, pp. 1 - 10 [articolo]Open Access
Casiglia E, Tikhonoff V, Virdis A, Grassi G, Angeli F, Barbagallo CM, Bombelli M, Cicero AFG, Cirillo M, Cirillo P, Dell'Oro R, D'elia L, Desideri G, Ferri C, Galletti F, Gesualdo L, Giannattasio C, Iaccarino G, Lippa L, Mallamaci F, Masi S, Maloberti A, Masulli M, Mazza A, Mengozzi A, Muiesan ML, Nazzaro P, Palatini P, Parati G, Pontremoli R, Quarti-Trevano F, Rattazzi M, Reboldi G, Rivasi G, Salvetti M, Tocci G, Ungar A, Verdecchia P, Viazzi F, Volpe M, Borghi C; Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension (SIIA)., Serum uric acid / serum creatinine ratio as a predictor of cardiovascular events. Detection of prognostic cardiovascular cut-off values, «JOURNAL OF HYPERTENSION», 2023, 41, pp. 180 - 186 [articolo]Open Access
Mengozzi A, Pugliese NR, Desideri G, Masi S, Angeli F, Barbagallo CM, Bombelli M, Cappelli F, Casiglia E, Cianci R, Ciccarelli M, Cicero AFG, Cirillo M, Cirillo P, Dell'Oro R, D'Elia L, Ferri C, Galletti F, Gesualdo L, Giannattasio C, Grassi G, Iaccarino G, Lippa L, Mallamaci F, Maloberti A, Masulli M, Mazza A, Muiesan ML, Nazzaro P, Palatini P, Parati G, Pontremoli R, Quarti-Trevano F, Rattazzi M, Reboldi G, Rivasi G, Russo E, Salvetti M, Tikhonoff V, Tocci G, Ungar A, Verdecchia P, Viazzi F, Volpe M, Borghi C, Virdis A; Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension (SIIA)., Serum Uric Acid Predicts All-Cause and Cardiovascular Mortality Independently of Hypertriglyceridemia in Cardiometabolic Patients without Established CV Disease: A Sub-Analysis of the URic acid Right for heArt Health (URRAH) Study, «METABOLITES», 2023, 13, Article number: 244, pp. 1 - 15 [articolo]Open Access
Fogacci F, Yerlitaş Sİ, Giovannini M, Zararsız G, Lido P, Borghi C, Cicero AFG, Sex X Time Interactions in Lp(a) and LDL-C Response to Evolocumab, «BIOMEDICINES», 2023, 11, Article number: 3271, pp. 1 - 11 [articolo]Open Access
Cicero AFG, Fogacci F, Bragagni A, Borghi C., Short-term evolocumab-induced tendon xanthomas regression in an elderly patient with homozygous familial hypercholesterolemia, «INTERNAL AND EMERGENCY MEDICINE», 2023, 18, pp. 307 - 310 [articolo]Open Access
